Validation of rotational thromboelastometry during cardiopulmonary bypass: A prospective, observational in-vivo study

European Journal of Anaesthesiology

Volumn 31, Issue 2, 2014, Pages 68-75

  Gronchi, Fabrizio ^a   Perret, Anouk ^a   Ferrari, Enrico ^a   Marcucci, Carine M ^a   Flèche, Jérome ^a   Crosset, Monique ^a   Schoettker, Patrick ^a   Marcucci, Carlo E ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; HEPARIN; PROTAMINE;

ADULT; AGED; ALGORITHM; BLOOD; BLOOD ANALYSIS; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; REVIEW; ROTATIONAL THROMBOELASTOMETRY; THROMBOCYTE;

AGED; ALGORITHMS; ANESTHESIOLOGY; ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; FACTOR XA; FEMALE; HEMOSTASIS; HEPARIN; HEPARIN ANTAGONISTS; HEPARIN LYASE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTAMINES; ROTATION; SWINE; THROMBELASTOGRAPHY; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 84893697387     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328363171a     Document Type: Review

References (20)

1. Ascione R, Williams S, Lloyd CT, et al. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 2001; 121:689-696.
2. Mehta RH, Sheng S, O'Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009; 2:583-590.
3. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009; 88:1162-1170.
4. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81:1650-1657.
5. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-2552.
6. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometryguided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009; 138:694-702.
7. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575-578.
8. Ho AM, Lee A, Chan SK, Ng SK. The timing for the use of heparinase and tromboelastography to prevent excessive bleeding coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2003; 17:413-414; author reply 414-415.
9. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547.
10. Schochl H, Maegele M, Solomon C, et al. Early and individualized goaldirected therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20:15.
11. Tuman KJ, McCarthy RJ, Djuric M, et al. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994; 8:144-149.
12. Gertler R, Wiesner G, Tassani-Prell P, et al. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine? J Cardiothorac Vasc Anesth 2011; 25:981-986.
13. Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 1988; 50:803-813.
14. Rapaport SI, Rao LV. The tissue factor pathway: how it has become a 'prima ballerina'. Thromb Haemost 1995; 74:7-17.
15. Hansen JB, Sandset PM, Huseby KR, et al. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man. Thromb Haemost 1996; 76:703-709.
16. Belcher PR, Muriithi EW, Milne EM, et al. Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass. Thromb Res 2000; 98:249-256.
17. Muriithi EW, Belcher PR, Day SP, et al. Lipolysis generates platelet dysfunction after in vivo heparin administration. Clin Sci (Lond) 2002; 103:433-440.
18. Bengtsson G, Olivecrona T. Lipoprotein lipase. Mechanism of product inhibition. Eur J Biochem 1980; 106:557-562.
19. Muriithi EW, Belcher PR, Day SP, et al. Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg 2000; 69:1827-1832.
20. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91:944-982.